Product NewsAvacta Announces AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing
Product NewsAvacta Demonstrates Key Performance Benefits of Affimer Technology for Affinity Separation
Industry NewsAvacta and Leeds University Awarded £3.8m Medical Research Council Funding to Develop New Diagnostic Tests
Industry NewsResearch Collaboration Looks to Develop CAR-T Cell Immunotherapy with Affimer Technology
Product NewsAvacta Analytical’s Optim® Technology Allows Straightforward Protein Characterization at the Netherlands Cancer Institute
